Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin
- Resource Type
- Authors
- Schelto Kruijff; Gooitzen M. van Dam; Willemijn Y. van der Plas; Patrick H. J. Hemmer; Judith E. K. R. Hentzen; Steven J de Jongh
- Source
- Journal of Surgical Oncology
- Subject
- 0301 basic medicine
Colorectal cancer
Review Article
GLOBAL CANCER STATISTICS
PHOTODYNAMIC THERAPY
0302 clinical medicine
Carcinoembryonic antigen
Medicine
molecular fluorescence‐guided surgery
Review Articles
Peritoneal Neoplasms
biology
Optical Imaging
peritoneal carcinomatosis
Cytoreduction Surgical Procedures
General Medicine
Molecular Imaging
Peritoneal carcinomatosis
PHASE-I
Surgery, Computer-Assisted
Oncology
030220 oncology & carcinogenesis
INDOCYANINE-GREEN
Hyperthermic intraperitoneal chemotherapy
Narrative review
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
Colorectal Neoplasms
Cytoreductive surgery
medicine.medical_specialty
Sentinel lymph node
review
colorectal cancer
molecular fluorescence-guided surgery
CARCINOEMBRYONIC ANTIGEN
03 medical and health sciences
Monitoring, Intraoperative
Humans
Neoplasm Invasiveness
Molecular fluorescence
business.industry
medicine.disease
Surgery
030104 developmental biology
CYTOREDUCTIVE SURGERY
ENDOTHELIAL GROWTH-FACTOR
biology.protein
SYSTEMIC CHEMOTHERAPY
business
SENTINEL LYMPH-NODE
- Language
- English
- ISSN
- 0022-4790
Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.